Published : Oct-2017
No. of Pages : 429
1 Table of Contents 2
1.1 List of Tables 9
1.2 List of Figures 20
2 Introduction 21
2.1 Inborn Gene or Chromosome Alterations Diagnostic Tests Overview 21
3 Products under Development 22
3.1 Inborn Gene or Chromosome Alterations Diagnostic Tests - Pipeline Products by Stage of Development 22
3.2 Inborn Gene or Chromosome Alterations Diagnostic Tests - Pipeline Products by Territory 23
3.3 Inborn Gene or Chromosome Alterations Diagnostic Tests - Pipeline Products by Regulatory Path 24
3.4 Inborn Gene or Chromosome Alterations Diagnostic Tests - Pipeline Products by Estimated Approval Date 25
3.5 Inborn Gene or Chromosome Alterations Diagnostic Tests - Ongoing Clinical Trials 26
4 Inborn Gene or Chromosome Alterations Diagnostic Tests - Pipeline Products under Development by Companies 27
4.1 Inborn Gene or Chromosome Alterations Diagnostic Tests Companies - Pipeline Products by Stage of Development 27
4.2 Inborn Gene or Chromosome Alterations Diagnostic Tests - Pipeline Products by Stage of Development 32
5 Inborn Gene or Chromosome Alterations Diagnostic Tests Companies and Product Overview 39
5.1 3D Signatures Inc Company Overview 39
5.2 AbaStar MDx Inc Company Overview 40
5.3 Abital Pharma Pipelines Ltd Company Overview 43
5.4 Agena Bioscience, Inc Company Overview 44
5.5 AIT Austrian Institute of Technology GmbH Company Overview 45
5.6 Alexion Pharmaceuticals Inc Company Overview 46
5.7 Amarantus Bioscience Holdings Inc Company Overview 47
5.8 Amity University Company Overview 48
5.9 Ariosa Diagnostics Inc Company Overview 49
5.10 Arrayit Diagnostics, Inc. Company Overview 50
5.11 Asuragen Inc Company Overview 51
5.12 Augusta University Company Overview 52
5.13 AutoGenomics Inc Company Overview 53
5.14 Avellino Lab USA Inc Company Overview 63
5.15 Baylor College of Medicine Company Overview 64
5.16 BCML GmbH Company Overview 65
5.17 BioCeps (Inactive) Company Overview 66
5.18 Biocept Inc Company Overview 67
5.19 Celula Inc Company Overview 68
5.20 Center for Biomedical Research in Network of Rare Diseases Company Overview 69
5.21 Children's Hospital Boston Company Overview 70
5.22 China Medical Technologies Inc (Inactive) Company Overview 72
5.23 ChipCare Corp Company Overview 73
5.24 Chronix Biomedical Inc Company Overview 74
5.25 Cincinnati Children's Hospital Medical Center Company Overview 75
5.26 Columbia University Company Overview 80
5.27 Da An Gene Co Ltd Company Overview 82
5.28 Decipher GenX, Inc. Company Overview 84
5.29 D-Kimia, LLC. Company Overview 87
5.30 Duke University Company Overview 89
5.31 DxTerity Diagnostics Inc Company Overview 90
5.32 ELITechGroup Inc Company Overview 91
5.33 Epinex Diagnostics Inc Company Overview 92
5.34 Eppendorf AG Company Overview 93
5.35 Fina Biotech SL Company Overview 94
5.36 Firalis SAS Company Overview 95
5.37 Fluidigm Corp Company Overview 96
5.38 Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung eV Company Overview 97
5.39 French National Institute of Health and Medical Research Company Overview 98
5.40 Genekam Biotechnology AG Company Overview 101
5.41 Genentech Inc Company Overview 102
5.42 Genetic Analysis AS Company Overview 103
5.43 GENEWIZ Inc Company Overview 105
5.44 German Cancer Research Center Company Overview 106
5.45 German Institute of Human Nutrition Company Overview 109
5.46 GILUPI Nanomedizin Company Overview 110
5.47 Good Start Genetics Inc Company Overview 111
5.48 Goodgene Inc Company Overview 113
5.49 Hadassah Medical Center Company Overview 114
5.50 Helicos BioSciences Corporation Company Overview 115
5.51 Helmholtz Center for Health and the Environment Munich Company Overview 116
5.52 Illumina, Inc. Company Overview 118
5.53 Immunexpress Pty Ltd Company Overview 121
5.54 Inform Genomics Inc Company Overview 124
5.55 Interleukin Genetics Inc Company Overview 126
5.56 International Biomedical Company Overview 127
5.57 Interpace Diagnostics, LLC Company Overview 128
5.58 John Hopkins University Company Overview 130
5.59 JS Genetics Inc Company Overview 133
5.60 Juneau Biosciences LLC Company Overview 134
5.61 KellBenx Inc Company Overview 136
5.62 Laboratory Corp of America Holdings Company Overview 138
5.63 Laval University Company Overview 139
5.64 LifeCodexx AG Company Overview 140
5.65 LineaGen Inc Company Overview 141
5.66 Maastricht University Medical Center Company Overview 142
5.67 Massachusetts Eye and Ear Infirmary Company Overview 143
5.68 Max-Delbruck-Centrum fur Molekulare Medizin (MDC) Company Overview 145
5.69 Medical Research Council Company Overview 146
5.70 Multiplicom NV Company Overview 147
5.71 Nanosphere Inc Company Overview 148
5.72 National Institute of Immunohaematology Company Overview 150
5.73 National University of Singapore Company Overview 151
5.74 NewGene Ltd Company Overview 153
5.75 Northwestern University Company Overview 156
5.76 NX PharmaGen Inc Company Overview 157
5.77 OncoGenesis Company Overview 158
5.78 Oxford Biodynamics Plc Company Overview 159
5.79 Oxford Gene Technology Ltd Company Overview 175
5.80 Paragon Medical Inc Company Overview 176
5.81 Population Bio Inc Company Overview 177
5.82 PreCyte, Inc. Company Overview 188
5.83 Predictive Therapeutics LLC Company Overview 189
5.84 Premaitha Health Plc Company Overview 192
5.85 Prenetics Inc Company Overview 194
5.86 Prognomix Inc Company Overview 195
5.87 Proove BioScience Inc Company Overview 197
5.88 Quest Diagnostics Inc Company Overview 200
5.89 R-Biopharm AG Company Overview 205
5.90 Sansure Biotech Inc Company Overview 206
5.91 Sapien Biosciences Company Overview 207
5.92 Seattle Children's Hospital Company Overview 209
5.93 Sequenom Inc Company Overview 210
5.94 Sequoia Genetics Company Overview 212
5.95 Sheba Medical Center Company Overview 213
5.96 SkylineDx BV Company Overview 214
5.97 Spartan Bioscience Inc Company Overview 215
5.98 Strand Life Sciences Pvt Ltd Company Overview 216
5.99 SUNY Upstate Medical University Company Overview 218
5.100 TAmiRNA GmbH Company Overview 219
5.101 TBG Diagnostics Ltd Company Overview 220
5.102 Tel Aviv University Company Overview 221
5.103 Transgenomic Inc Company Overview 222
5.104 Transplant Genomics Inc. Company Overview 223
5.105 TrovaGene Inc Company Overview 226
5.106 Tufts Medical Center Company Overview 228
5.107 University Hospital of Cologne Company Overview 229
5.108 University of Arizona Company Overview 232
5.109 University of California San Francisco Company Overview 233
5.110 University of Cape Town Company Overview 234
5.111 University of Central Florida Company Overview 235
5.112 University of Colorado Company Overview 237
5.113 University of Illinois at Chicago Company Overview 238
5.114 University of Maryland Company Overview 239
5.115 University of Michigan Company Overview 240
5.116 University of Utah Company Overview 242
5.117 Vaiomer SAS Company Overview 243
5.118 Vanadis Diagnostics AB Company Overview 245
5.119 Veritas Genetics Company Overview 246
5.120 VitaPath Genetics, Inc. Company Overview 248
5.121 Weizmann Institute of Science Company Overview 249
5.122 Xiamen Zeesan Biotech Co.,Ltd Company Overview 250
5.123 XRGenomics LTD Company Overview 251
5.124 Yale University Company Overview 253
5.125 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd Company Overview 255
6 Inborn Gene or Chromosome Alterations Diagnostic Tests- Recent Developments 257
6.1 Sep 07, 2017: Further patent infringement claims received from Illumina & Sequenom 257
6.2 Sep 07, 2017: Eurofins Genoma Introduces GeneSafe - The First Non-Invasive Prenatal Test That Screens for Single-Gene Disorders 257
6.3 Aug 29, 2017: Premaitha approved for Good Manufacturing Practice by ANVISA Brazil 258
6.4 Aug 24, 2017: LabCorp Names Nationally Recognized Health-Policy Expert Dr. Brian Caveney As Enterprise-Wide Chief Medical Officer 258
6.5 Aug 15, 2017: GeneNews Announces Q2-2017 Financial Results & Provides Progress Update 259
6.6 Aug 09, 2017: Trovagene Announces Second Quarter 2017 Company Highlights and Financial Results 260
6.7 Aug 08, 2017: Natera Reports Second Quarter 2017 Financial Results 262
6.8 Aug 07, 2017: Luminex Reports Second Quarter 2017 Financial Results 263
6.9 Aug 03, 2017: Fluidigm Announces Second Quarter Financial Results and Operational Progress 264
6.10 Aug 03, 2017: CombiMatrix Reports Second Quarter 2017 Financial and Operating Results 265
6.11 Aug 02, 2017: Hologic Announces Financial Results for Third Quarter of Fiscal 2017 266
6.12 Aug 01, 2017: GenMark Reports Second Quarter 2017 Results 268
6.13 Aug 01, 2017: llumina Reports Strong Financial Results for Second Quarter of Fiscal Year 2017 269
6.14 Aug 01, 2017: Novel Genetic Test Could Help Combat the Opioid Epidemic by Identifying Patients at Risk of Addiction 270
6.15 Aug 01, 2017: Illumina Reports Strong Financial Results for Second Quarter of Fiscal Year 2017 270
6.16 Jul 28, 2017: ORYZON Reports Financial Results and Corporate Update for the 1st Half Ended June 30, 2017 271
6.17 Jul 27, 2017: QIAGEN Reports Results for Second Quarter and First Half of 2017 273
6.18 Jul 26, 2017: LabCorp Announces Record Results in the Second Quarter of 2017 and Increases 2017 Guidance 276
6.19 Jul 26, 2017: Thermo Fisher Scientific Reports Second Quarter 2017 Results 279
6.20 Jul 25, 2017: Quest Diagnostics Reports Second Quarter 2017 Financial Results, Raises 2017 Financial Outlook 281
6.21 Jul 18, 2017: LabCorp's William Hanlon Appointed to Governing Committee of the National Evaluation System for health Technology Coordinating Center 281
6.22 Jul 11, 2017: Integragen Reports Continued Growth During 1st Half Of 2017 282
6.23 Jul 10, 2017: Premaitha announces two laboratory hub contracts in South East Asia 282
6.24 Jul 10, 2017: Trovagene Regains Compliance with NASDAQ Listing Requirements 283
6.25 Jul 03, 2017: Premaitha Health Litigation Update 283
6.26 Jul 03, 2017: Interleukin Genetics To Explore Strategic Alternatives, Reduce Workforce 283
7 Appendix 423
7.1 Methodology 423
7.2 About GlobalData 426
7.3 Contact Us 426
7.4 Disclaimer 426
1.1 List of Tables
Table 1: Inborn Gene or Chromosome Alterations Diagnostic Tests - Pipeline Products by Stage of Development 25
Table 2: Inborn Gene or Chromosome Alterations Diagnostic Tests - Pipeline Products by Territory 26
Table 3: Inborn Gene or Chromosome Alterations Diagnostic Tests - Pipeline Products by Regulatory Path 27
Table 4: Inborn Gene or Chromosome Alterations Diagnostic Tests - Pipeline Products by Estimated Approval Date 28
Table 5: Inborn Gene or Chromosome Alterations Diagnostic Tests - Ongoing Clinical Trials 29
Table 6: Inborn Gene or Chromosome Alterations Diagnostic Tests Companies - Pipeline Products by Stage of Development 30
Table 7: Inborn Gene or Chromosome Alterations Diagnostic Tests - Pipeline Products by Stage of Development 35
Table 8: 3D Signatures Inc Pipeline Products & Ongoing Clinical Trials Overview 42
Table 9: 3D Telo-AD Test - Product Status 42
Table 10: 3D Telo-AD Test - Product Description 42
Table 11: AbaStar MDx Inc Pipeline Products & Ongoing Clinical Trials Overview 43
Table 12: Molecular Diagnostic Test - Bipolar Disorder - Product Status 43
Table 13: Molecular Diagnostic Test - Bipolar Disorder - Product Description 43
Table 14: Molecular Diagnostic Test - Depression - Product Status 44
Table 15: Molecular Diagnostic Test - Depression - Product Description 44
Table 16: Molecular Diagnostic Test - Parkinson's Disease - Product Status 44
Table 17: Molecular Diagnostic Test - Parkinson's Disease - Product Description 45
Table 18: Molecular Diagnostic Test - Schizophrenia - Product Status 45
Table 19: Molecular Diagnostic Test - Schizophrenia - Product Description 45
Table 20: Abital Pharma Pipelines Ltd Pipeline Products & Ongoing Clinical Trials Overview 46
Table 21: Diagnostic Assay - Parkinson's Disease - Product Status 46
Table 22: Diagnostic Assay - Parkinson's Disease - Product Description 46
Table 23: Agena Bioscience, Inc Pipeline Products & Ongoing Clinical Trials Overview 47
Table 24: Sensigene Trisomy 21 Laboratory Developed Test - Product Status 47
Table 25: Sensigene Trisomy 21 Laboratory Developed Test - Product Description 47
Table 26: AIT Austrian Institute of Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview 48
Table 27: Diagnostic Tool - Fibroproliferative Wound Healing - Product Status 48
Table 28: Diagnostic Tool - Fibroproliferative Wound Healing - Product Description 48
Table 29: Alexion Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 49
Table 30: SmartPanel - Product Status 49
Table 31: SmartPanel - Product Description 49
Table 32: Amarantus Bioscience Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 50
Table 33: Diagnostic Test - IFN-Beta Resistance - Product Status 50
Table 34: Diagnostic Test - IFN-Beta Resistance - Product Description 50
Table 35: Amity University Pipeline Products & Ongoing Clinical Trials Overview 51
Table 36: Prenatal Screening Kit - Product Status 51
Table 37: Prenatal Screening Kit - Product Description 51
Table 38: Ariosa Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 52
Table 39: Harmony Prenatal Test - Product Status 52
Table 40: Harmony Prenatal Test - Product Description 52
Table 41: Arrayit Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 53
Table 42: PDx Pre-Symptomatic Test - Product Status 53
Table 43: PDx Pre-Symptomatic Test - Product Description 53
Table 44: Asuragen Inc Pipeline Products & Ongoing Clinical Trials Overview 54
Table 45: Signature CF Expand - Product Status 54
Table 46: Signature CF Expand - Product Description 54
Table 47: Augusta University Pipeline Products & Ongoing Clinical Trials Overview 55
Table 48: SUMO Gene Test - Type 1 Diabetes - Product Status 55
Table 49: SUMO Gene Test - Type 1 Diabetes - Product Description 55
Table 50: AutoGenomics Inc Pipeline Products & Ongoing Clinical Trials Overview 56
Table 51: DNA Guided Diagnostic Test - Cardiovascular Disease - Product Status 56
Table 52: DNA Guided Diagnostic Test - Cardiovascular Disease - Product Description 57
Table 53: DNA Guided Diagnostic Test - Diabetes - Product Status 57
Table 54: DNA Guided Diagnostic Test - Diabetes - Product Description 57
Table 55: DNA Guided Diagnostic Test - Obesity - Product Status 58
Table 56: DNA Guided Diagnostic Test - Obesity - Product Description 58
Table 57: INFINITI CFTR-31 Assay - Product Status 58
Table 58: INFINITI CFTR-31 Assay - Product Description 59
Table 59: INFINITI Factor II-V And MTHFR Assay - Product Status 59
Table 60: INFINITI Factor II-V And MTHFR Assay - Product Description 59
Table 61: INFINITI FMF Assay - Product Status 60
Table 62: INFINITI FMF Assay - Product Description 60
Table 63: INFINITI MTHFR Assay - Product Status 60
Table 64: INFINITI MTHFR Assay - Product Description 61
Table 65: INFINITI SMART - Factor II - Product Status 61
Table 66: INFINITI SMART - Factor II - Product Description 61
Table 67: INFINITI SMART - Factor V - Product Status 62
Table 68: INFINITI SMART - Factor V - Product Description 62
Table 69: INFINITI SMART - MTHFR - Product Status 62
Table 70: INFINITI SMART - MTHFR - Product Description 63
Table 71: INFINITI System Assay For Factor II - Product Status 63
Table 72: INFINITI System Assay For Factor II - Product Description 63
Table 73: INFINITI System Assay For Factor II-V Leiden - Product Status 64
Table 74: INFINITI System Assay For Factor II-V Leiden - Product Description 64
Table 75: INFINITI System Assay For Factor V Leiden - Product Status 64
Table 76: INFINITI System Assay For Factor V Leiden - Product Description 65
Table 77: Avellino Lab USA Inc Pipeline Products & Ongoing Clinical Trials Overview 66
Table 78: Keratoconus Screening Test - Product Status 66
Table 79: Keratoconus Screening Test - Product Description 66
Table 80: Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 67
Table 81: Diagnostic Assay - Rett Syndrome - Product Status 67
Table 82: Diagnostic Assay - Rett Syndrome - Product Description 67
Table 83: BCML GmbH Pipeline Products & Ongoing Clinical Trials Overview 68
Table 84: Prenatal Diagnosis Biochip - Product Status 68
Table 85: Prenatal Diagnosis Biochip - Product Description 68
Table 86: BioCeps (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 69
Table 87: Prenatal Diagnostic Test - Product Status 69
Table 88: Prenatal Diagnostic Test - Product Description 69
Table 89: Biocept Inc Pipeline Products & Ongoing Clinical Trials Overview 70
Table 90: preCEED - Product Status 70
Table 91: preCEED - Product Description 70
Table 92: Celula Inc Pipeline Products & Ongoing Clinical Trials Overview 71
Table 93: Non-Invasive Pre-Natal Test - Product Status 71
Table 94: Non-Invasive Pre-Natal Test - Product Description 71
Table 95: Center for Biomedical Research in Network of Rare Diseases Pipeline Products & Ongoing Clinical Trials Overview 72
Table 96: Diagnostic Kit - HHT - Product Status 72
Table 97: Diagnostic Kit - HHT - Product Description 72
Table 98: Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 73
Table 99: Diagnostic Assay - Cystic Fibrosis - Product Status 73
Table 100: Diagnostic Assay - Cystic Fibrosis - Product Description 73
Table 101: Diagnostic Assay - Developmental Delay - Product Status 74
Table 102: Diagnostic Assay - Developmental Delay - Product Description 74
Table 103: China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 75
Table 104: SPR Based DNA Chip - Coagulation Related Disorders - Product Status 75
Table 105: SPR Based DNA Chip - Coagulation Related Disorders - Product Description 75
Table 106: ChipCare Corp Pipeline Products & Ongoing Clinical Trials Overview 76
Table 107: HIV Assay - Infants - Product Status 76
Table 108: HIV Assay - Infants - Product Description 76
Table 109: Chronix Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 77
Table 110: Companion Diagnostic Test - HPV - Product Status 77
Table 111: Companion Diagnostic Test - HPV - Product Description 77
Table 112: Cincinnati Children's Hospital Medical Center Pipeline Products & Ongoing Clinical Trials Overview 78
Table 113: Diagnostic Assay - Asthma - Product Status 78
Table 114: Diagnostic Assay - Asthma - Product Description 78
Table 115: Diagnostic Assay - Crohn's Disease - Product Status 79
Table 116: Diagnostic Assay - Crohn's Disease - Product Description 79
Table 117: Diagnostic Biomarker - Biliary Atresia - Product Status 79
Table 118: Diagnostic Biomarker - Biliary Atresia - Product Description 80
Table 119: Fetal Maturity Assessment Test - Product Status 80
Table 120: Fetal Maturity Assessment Test - Product Description 80
Table 121: Gene Chip Based Diagnostic Test - Liver Diseases - Product Status 81
Table 122: Gene Chip Based Diagnostic Test - Liver Diseases - Product Description 81
Table 123: Genetic Marker Diagnostic Test - Food Allergy - Product Status 81
Table 124: Genetic Marker Diagnostic Test - Food Allergy - Product Description 82
Table 125: Columbia University Pipeline Products & Ongoing Clinical Trials Overview 83
Table 126: Biomarker-Based Diagnostic Test - Autism - Product Status 83
Table 127: Biomarker-Based Diagnostic Test - Autism - Product Description 83
Table 128: Diagnostic Biomarker Test - Schizophrenia - Product Status 84
Table 129: Diagnostic Biomarker Test - Schizophrenia - Product Description 84
Table 130: Da An Gene Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 85
Table 131: Real Time PCR Kit - Alpha-Mediterranean Anaemia - Product Status 85
Table 132: Real Time PCR Kit - Alpha-Mediterranean Anaemia - Product Description 85
Table 133: Real Time PCR Kit - Beta-Mediterranean Anaemia - Product Status 86
Table 134: Real Time PCR Kit - Beta-Mediterranean Anaemia - Product Description 86
Table 135: Decipher GenX, Inc. Pipeline Products & Ongoing Clinical Trials Overview 87
Table 136: Diagnostic Assay - Athletic Overtraining - Product Status 87
Table 137: Diagnostic Assay - Athletic Overtraining - Product Description 87
Table 138: Diagnostic Test - Chronic Fatigue Syndrome - Product Status 88
Table 139: Diagnostic Test - Chronic Fatigue Syndrome - Product Description 88
Table 140: Diagnostic Test - Fibromyalgia - Product Status 88
Table 141: Diagnostic Test - Fibromyalgia - Product Description 89
Table 142: Diagnostic Test - Major Depression - Product Status 89
Table 143: Diagnostic Test - Major Depression - Product Description 89
Table 144: D-Kimia, LLC. Pipeline Products & Ongoing Clinical Trials Overview 90
Table 145: Diagnostic Assay - Malaria - Product Status 90
Table 146: Diagnostic Assay - Malaria - Product Description 90
Table 147: Diagnostic Assay - Tuberculosis - Product Status 91
Table 148: Diagnostic Assay - Tuberculosis - Product Description 91
Table 149: Duke University Pipeline Products & Ongoing Clinical Trials Overview 92
Table 150: Diagnostic Blood Test - Respiratory Infections - Product Status 92
Table 151: Diagnostic Blood Test - Respiratory Infections - Product Description 92
Table 152: DxTerity Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 93
Table 153: RadTox Test - Product Status 93
Table 154: RadTox Test - Product Description 93
Table 155: ELITechGroup Inc Pipeline Products & Ongoing Clinical Trials Overview 94
Table 156: Eon 100 Automated Chemistry Analyzer - UIBC Assay - Product Status 94
Table 157: Eon 100 Automated Chemistry Analyzer - UIBC Assay - Product Description 94
Table 158: Epinex Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 95
Table 159: Down Syndrome Screen Test - Product Status 95
Table 160: Down Syndrome Screen Test - Product Description 95
Table 161: Eppendorf AG Pipeline Products & Ongoing Clinical Trials Overview 96
Table 162: Rheumagene Diagnostic Test - Product Status 96
Table 163: Rheumagene Diagnostic Test - Product Description 96
1.2 List of Figures
Figure 1: Inborn Gene or Chromosome Alterations Diagnostic Tests - Pipeline Products by Stage of Development 25
Figure 2: Inborn Gene or Chromosome Alterations Diagnostic Tests - Pipeline Products by Territory 26
Figure 3: Inborn Gene or Chromosome Alterations Diagnostic Tests - Pipeline Products by Regulatory Path 27
Figure 4: Inborn Gene or Chromosome Alterations Diagnostic Tests - Pipeline Products by Estimated Approval Date 28
Figure 5: Inborn Gene or Chromosome Alterations Diagnostic Tests - Ongoing Clinical Trials 29
